Leflunomide Tablet shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting Jun 8, 2026 · last update Jun 8, 2026
Manufacturers: Sanofi-Aventis U.S. LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Arava, Tablet, 10 mg (NDC 0088-2160-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 8, 2026 Updated Jun 8, 2026 Discontinued Jun 8, 2026 |
| Arava, Tablet, 20 mg (NDC 0088-2161-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 8, 2026 Updated Jun 8, 2026 Discontinued Jun 8, 2026 |
| Arava, Tablet, 100 mg (NDC 0088-2162-33) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 8, 2026 Updated Jun 8, 2026 Discontinued Jun 8, 2026 |
| Leflunomide, Tablet, 10 mg (NDC 0955-1735-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 8, 2026 Updated Jun 8, 2026 Discontinued Jun 8, 2026 |
| Leflunomide, Tablet, 20 mg (NDC 0955-1737-30) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jun 8, 2026 Updated Jun 8, 2026 Discontinued Jun 8, 2026 |